Guaifenesin in rhinitis

Current Allergy and Asthma Reports

Volumn 9, Issue 2, 2009, Pages 101-106

  Storms, William ^a   Farrar, Judith R ^b  

^a William Storms Allergy Clinic   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARBOHYDRATE; CODEINE; DEXTROMETHORPHAN; ELECTROLYTE; GLYCOPROTEIN; GUAIFENESIN; LIPID; PLACEBO; WATER;

ADJUVANT THERAPY; ALLERGY; CILIARY MOTILITY; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; COUGHING; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRY NOSE; ELASTICITY; FLOW KINETICS; FLUID INTAKE; FOOD AND DRUG ADMINISTRATION; HUMAN; HYDRATION; IMMUNITY; LAVAGE; MONOTHERAPY; MUCOCILIARY CLEARANCE; MUCUS SECRETION; NOSE MUCUS; RECOMMENDED DRUG DOSE; RESPIRATORY EPITHELIUM; RESPIRATORY TRACT INFECTION; REVIEW; RHINITIS; SINGLE DRUG DOSE; TREATMENT DURATION; UNITED STATES; VISCOSITY;

COUGH; EXPECTORANTS; GUAIFENESIN; HUMANS; MUCUS; RESPIRATORY MUCOSA; RESPIRATORY SYSTEM; RESPIRATORY TRACT INFECTIONS; RHINITIS;

EID: 60349125725     PISSN: 15297322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11882-009-0015-4     Document Type: Review

References (27)

1. Dicpinigaitis PV, Gayle YE: Effect of guaifenesin on cough reflex sensitivity. Chest 2003, 124:2178-2181.
2. Bousquet J, Khaltaev N, Cruz AA, et al.: Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA2LEN and AllerGen). Allergy 2008, 63:S8-S160.
3. Wallace DV, Dykewicz MS, Bernstein DI, et al.: The diagnosis and management of rhinitis: An updated practice parameter. J Allergy Clin Immunol 2008, 122:S1-S84.
4. Slavin RG, Spector SL, Bernstein IL, et al.; American Academy of Allergy, Asthma and Immunology; American College of Allergy, Asthma and Immunology; Joint Council of Allergy, Asthma and Immunology: The diagnosis and management of sinusitis: A practice parameter update. J Allergy Clin Immunol 2005, 116:S13-S47.
5. Bolser DC: Cough suppressant and pharmacologic protussive therapy: ACCP evidence-based clinical practice guidelines. Chest 2006, 129:238S-249S.
6. Braga PC, Allegra L, eds: Drugs in Bronchial Mucology. New York: Raven Press; 1989.
7. Yuta A, Baraniuk JN: Therapeutic approaches to mucus hypersecretion. Curr Allergy Asthma Rep 2005, 5:243-251.
8. Scarupa MD, Kaliner MA: Adjuvant therapies in the treatment of acute and chronic rhinosinusitis. Clin Allergy Immunol 2007, 20:251-262.
9. United States Department of Health and Human Services: Expectorant drug products for over-the-counter human use: Final monograph. Fed Regist 1989, 54:8494-8509.
10. Baraniuk JN, Kaliner MA: Pharmacology of nasal secretions. In Pharmacology of the Respiratory Tract. Edited by Cheung KF, Barnes PJ. New York: Marcel Dekker; 1993:551-582.
11. Stannard W, O'Callaghan C: Ciliary function and the role of cilia in clearance. J Aerosol Med 2006, 19:110-115.
12. Houtmeyers E, Gosselink R, Gayan-Ramirez G, Decramer M: Regulation of mucociliary clearance in health and disease. Eur Respir J 1999, 13:1177-1188.
13. Kaliner MA: Human host defense and sinusitis. In Diseases of the Sinuses. Edited by Gershwin ME, Incaudo GA. Totowa, NJ: Humana Press; 1996:53-62.
14. Kaliner MA, ed: Current Review of Rhinitis. Philadelphia: Current Medicine Group LLC; 2002.
15. Houtmeyers E, Gosselink R, Gayan-Ramirez G, et al.: Effects of drugs on mucus clearance. Eur Respir J 1999, 14:452-467.
16. Moore EJ, KerA EB: Atrophic rhinitis: a review of 242 cases. Am J Rhinol 2001, 15:355-361.
17. Atsuta S, Majima Y: Nasal mucociliary clearance of chronic sinusitis in relation to rheological properties of nasal mucus. Ann Otol Rhinol Laryngol 1998, 107:47-51.
18. Rubin BK: Mucolytics, expectorants, and mucokinetic medications. Respir Care 2007, 52:859-865.
19. Robinson RE, Cummings WB, Deffenbaugh ER: Effectiveness of guaifenesin as an expectorant: A cooperative double-blind study. Curr Ther Res 1977, 22:284-296.
20. Hirsch SR, Viernes PF, Kory RC: The expectorant effect of glyceryl guaiacolate in patients with chronic bronchitis: A controlled in vitro and in vivo study. Chest 1973, 63:9-14.
21. Wawrose SF, Tami TA, Amoils P: The role of guaifenesin in the treatment of sinonasal disease in patients infected with the human immunodeficiency virus (HIV). Laryngoscope 1992, 102:1225-1228.
22. Rosen EJ, Calhoun KH: Alterations of nasal mucociliary clearance in association with HIV infection and the effect of guaifenesin therapy. Laryngoscope 2005, 115:27-30.
23. Rubin BK: An in vitro comparison of the mucoactive properties of guaifenesin, iodinated glycerol, surfactant, and albuterol. Chest 1999, 116:195-200.
24. Kuhn JJ, Hendley O, Adams KF, et al.: Antitussive effect of guaifenesin in young adults with natural colds. Chest 1982, 82:713-718.
25. Storms W, Kaliner MA, Javidi M, et al.: A real world open-label multicenter single group study to evaluate patients' reactions to Mucinex (single-entity long-acting guaifenesin). J Allergy Clin Immunol 2007, 119:S229.
26. Croughan-Minibane MS, Patitti DB, Rodnick JE, Eliaser G: Clinical trial examining effectiveness of three cough syrups. J Am Board Fam Pract 1993, 6:109-115.
27. Kaliner MA, Storms W, Javidi M, et al.: Sub-group analysis of patients using antibiotics and treated with single-entity long-acting guaifenesin. Paper presented at the 2008 Annual Meeting of the Western Society of Allergy, Asthma, and Immunology. Kailua-Kona, HI; January 21-25, 2008.